[1]任秋月,常柏.水陆二仙丹合抵挡汤加减治疗早期糖尿病肾病的前瞻性研究[J].西部中医药,2021,34(07):9-12.[doi:10.12174/j.issn.2096-9600.2021.07.03]
　REN Qiuyue,CHANG Bai.Prospective Study on Modified Shuilu Erxian Pills and Didang Decoction in the Treatment of Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2021,34(07):9-12.[doi:10.12174/j.issn.2096-9600.2021.07.03]
点击复制

水陆二仙丹合抵挡汤加减治疗早期糖尿病肾病的前瞻性研究
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
34
期数:
2021年07期
页码:
9-12
栏目:
临床论著
出版日期:
2021-07-15

文章信息/Info

Title:
Prospective Study on Modified Shuilu Erxian Pills and Didang Decoction in the Treatment of Early Diabetic Nephropathy
作者:
任秋月1,2, 常柏1,2
1.天津中医药大学，天津 301617
2.天津医科大学朱宪彝纪念医院
Author(s):
REN Qiuyue1,2, CHANG Bai1,2
1.Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China
2.Tianjin Medical University Chu Hisen-I Memorial Hospital
关键词:
糖尿病肾病; 早期; 水陆二仙丹; 抵挡汤; 前瞻性研究
Keywords:
diabetic nephropathy;  early; pills; decoction; prospective study
分类号:
R255.4
DOI:
10.12174/j.issn.2096-9600.2021.07.03
摘要:
目的评价水陆二仙丹合抵挡汤加减治疗早期糖尿病肾病（diabetic nephropathy，DN）的疗效。 方法将早期DN患者102例根据随访期间的暴露因素（是否服用水陆二仙丹合抵挡汤加减治疗）分为无暴露组和暴露组，无暴露组服用水陆二仙丹合抵挡汤加减治疗时间＜4周，低暴露组为4～8周，高暴露组为8～16周。观察水陆二仙丹合抵挡汤加减治疗与终点事件（DNⅢ期进展到临床蛋白尿期）及次要结局指标［临床症状、空腹血糖（fasting blood glucose，FBG）、餐后2 h血糖（2-hour postprandial blood glucose，2 h PG）、总胆固醇（total cholesterol，TC）、甘油三酯（triglyceride，TG）、低密度脂蛋白（low density lipoprotein cholesterol，LDL-C）、尿微量白蛋白排泄率（urinary albumin excretion rate，UAER）、24 h尿蛋白定量（24-hour urinary protein quantity,24 h UPQ）、血肌酐（serum creatinine，SCr）、尿素氮（blood urea nitrogen，BUN）］的关系。 结果不同暴露水平终点事件发生率比较差异无统计学意义（P＞0.05）；低、高暴露组患者腰膝酸软、倦怠乏力、口干、夜尿多症状较无暴露组改善明显（P＜0.05）；低、高暴露组FBG、TG、UAER、24 h UPQ、SCr均降低（P＜0.05），且高暴露组FBG、TG、UAER、SCr降低更明显（P＜0.05），而PPG、LDL、BUN低、高暴露组比较差异无统计学意义（P＞0.05）。 结论在综合治疗基础上服用水陆二仙丹合抵挡汤加减4～16周可明显缓解早期DN患者临床症状，降低FBG、TG、UAER、SCr水平。
Abstract:
ObjectiveTo assess clinical efficacy of Shuilu Erxian pills joined with modified Didang decoction (SDD) in the treatment of early diabetic nephropathy (DN). MethodsAll 102 early DN patients were divided into non-exposure group and exposure group according to the exposure factor during the follow-up period (whether the patients were treated with Shuilu Erxian pills and modified SDD), non-exposure group took Shuilu Erxian pills joined with modified Didang decoction, therapeutic time less than four weeks, four to eight weeks in low exposure group, eight to 16 weeks in high exposure group. To observe the correlation between treatment and end point events (progression from DN stage III to clinical proteinuria) and secondary outcome measures (clinical symptoms, FBG, 2 h PG, TC, TG, LDL-C, UAER, 24 h UPQ, SCr and BUN). ResultsThe difference had no statistical meaning in the incidence of endpoint events at different exposure levels (P>0.05); the improvements of the symptoms including soreness of waist and knees, fatigue, dry mouth, nocturia in low and high exposure group were more notable compared with these of non-exposure group (P<0.05); FBG, TG, UAER, 24 h UPQ and SCr lowered in low and high exposure group (P<0.05), FBG, TG, UAER and SCr of high exposure group reduced remarkably (P<0.05), while the difference had no statistical menaing in PPG, LDL and BUN between low and high exposure group (P>0.05). ConclusionOn the foundation of comprehensive therapy, the administration of Shuilu Erxian pills joined with modified SDD for four to 16 weeks could notably relieve clinical symptoms in early DN patients and lower the levels of FBG, TG, UAER and SCr.

相似文献/References:

[1]徐宏.益水生新饮对高血压早期肾损害患者血液流变学及ALB和α1-MG的影响*[J].西部中医药,2013,26(06):4.
　XU Hong.Effects of Y iShui ShengXinY in on Hemorheology, ALB and α1-MG of Hypertensive Patients with Early Renal Damage[J].Western Journal of Traditional Chinese Medicine,2013,26(07):4.
[2]王学琦,李丰华,张荣华,等.温肾汤治疗早期糖尿病肾病80例[J].西部中医药,2013,26(09):62.
　WANG Xueqi,LI Fenghua,ZHANG Ronghua,et al.WenShenTang for 80 Cases of Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(07):62.
[3]任芳,徐厚谦△.黄芪注射液治疗糖尿病肾病有效性及安全性的系统评价[J].西部中医药,2014,27(01):77.
　REN Fang,XU Houqian.Systematic Review of the Effectiveness and Safety of HuangQi Injection in Treating Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2014,27(07):77.
[4]丁夏楠,许筠△,苏建平,等.益肾逐瘀方治疗糖尿病肾病蛋白尿37例[J].西部中医药,2014,27(04):96.
　DING Xianan,XU Jun,SU Jianping,et al.Treatment for Proteinuria of 37 Patients with Diabetic Nephropathy by Kidney-invigorating Stagnation-dispelling Prescription[J].Western Journal of Traditional Chinese Medicine,2014,27(07):96.
[5]肖远莉.循证护理的优效性及影响因素分析———来自终末期糖尿病肾病患者血液透析的证据[J].西部中医药,2014,27(08):127.
[6]柳青梅.舒适护理在剖宫产产妇术后护理中的应用[J].西部中医药,2014,27(08):140.
[7]刘涛.缬沙坦联合复方丹参滴丸对早期2型糖尿病肾病患者尿微量白蛋白的影响[J].西部中医药,2015,28(05):106.
[8]张鉴明.加味生化汤联合米非司酮、米索前列醇治疗早期妊娠药物流产200例[J].西部中医药,2013,26(04):77.
　ZHANG Jianming.Modified ShengHuaTang Combined with Mifepristone and Misoprostol in Treating 200 Cases of Drug Abortion for Patients in Early Pregnancy[J].Western Journal of Traditional Chinese Medicine,2013,26(07):77.
[9]连琯,史晓伟.当归补血汤合金水宝治疗早期糖尿病肾病16例临床观察[J].西部中医药,2013,26(06):68.
　LIAN Guan,SHI Xiaowei.Clinical Observation on DangGui BuXueTang and JinShuiBao in Treating 16 Cases of Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(07):68.
[10]任芳,徐厚谦△.黄芪注射液治疗糖尿病肾病随机对照试验报告质量评价[J].西部中医药,2013,26(12):1.
　REN Fang,XU Houqian.Quality Evaluation of the Report for Randomized Controlled Trials of HuangQi Injection in Treating Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(07):1.
[11]林晓芬,黄燕璇.益肾汤联合厄贝沙坦及胰激肽原酶治疗早期糖尿病肾病的疗效观察[J].西部中医药,2013,26(07):68.
　LIN Xiaofen,HUANG Yanxuan.Clinical Observation on YiShenTang Combined with Irbesartan and Pancreatic Kininogenase in the Treatment for Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(07):68.
[12]王永军,石良静,等.益气养阴通络方对早期糖尿病肾病患者炎症因子及肾功能的影响[J].西部中医药,2020,33(05):82.[doi:10.12174/j.issn.1004-6852.2020.05.23]
　WANG Yongjun,SHI Liangjing,FAN Zhengchao,et al.Influence of Qi-invigorating Yin-nourishing Collateral-dredging Prescription on Inflammatory Factors and Renal Function of the Patients with Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2020,33(07):82.[doi:10.12174/j.issn.1004-6852.2020.05.23]
[13]朱祎,李晓华.叶氏益肾降糖方治疗早期糖尿病肾病疗效观察[J].西部中医药,2020,33(07):118.[doi:10.12174/j.issn.1004-6852.2020.07.31]
　ZHU Yi,LI Xiaohua.Clinical Effects of Ye′s Yishen Jiangtang Prescription in Treating Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2020,33(07):118.[doi:10.12174/j.issn.1004-6852.2020.07.31]
[14]吕翠岩,郑爽,贾晓蕾,等.参芪地黄汤化裁方对早期糖尿病肾病患者血糖及尿蛋白的影响[J].西部中医药,2021,34(09):51.[doi:10.12174/j.issn.2096-9600.2021.09.14]
　LYU Cuiyan,ZHENG Shuang,JIA Xiaolei,et al.Effects of Modified Prescription of Shenqi Dihuang Decoction on Blood Glucose and Urinary Protein in Early Diabetic Kidney Disease[J].Western Journal of Traditional Chinese Medicine,2021,34(07):51.[doi:10.12174/j.issn.2096-9600.2021.09.14]

备注/Memo

备注/Memo:
任秋月（1991—）女，在读博士研究生。研究方向：糖尿病及其并发症的中西医结合治疗。国家自然科学基金面上项目（81473622，81973614）。
更新日期/Last Update: 2021-07-15